Search This Blog

Tuesday, July 23, 2019

Edwards Lifesciences EPS beats by $0.05, beats on revenue

Edwards Lifesciences (NYSE:EW): Q2 Non-GAAP EPS of $1.38 beats by $0.05; GAAP EPS of $1.14 misses by $0.18.
Revenue of $1.09B (+15.5% Y/Y) beats by $50M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)